Skip to main content
SpringerLink
Log in

Gabapentinoid dosing often inappropriate in CKD, no association with AEs

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Wells DA, et al. Gabapentinoid dosing and adverse events in patients with chronic kidney disease Clinical Nephrology : 18 Jul 2022. Available from: URL: http://doi.org/10.5414/CN110815

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gabapentinoid dosing often inappropriate in CKD, no association with AEs. Reactions Weekly 1917, 9 (2022). https://doi.org/10.1007/s40278-022-19880-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-19880-1

Search

Navigation